Viewing Study NCT02097966


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-04-12 @ 4:52 PM
Study NCT ID: NCT02097966
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2016-01-27
First Post: 2014-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module